HI Earnings

HI reported its FY2026Q1 earnings on 2026-02-04, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following HI's FY2026Q1 earnings announcement on 2026-02-04, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, HI's stock price tends to shift by an average of +1.13% in the 10 days leading up to earnings and -1.29% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate HI’s annual revenue to reach 607.00M, while the EPS is projected at 1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between HI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HI's stock price typically moves by +1.13% in the 10 days before its earnings and -1.29% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.00 and revenue of 607.00M.

The earnings call reveals several negative indicators: decreased revenue guidance, lower adjusted EBITDA, and a significant tariff impact. The Q&A highlights uncertainties in cash flow and leverage, with management avoiding clear guidance on dividends. Despite some positive developments in orders and demand, the overall sentiment is cautious due to declining margins and backlog, as well as a competitive pricing environment. Given the market cap, the stock is likely to experience a negative reaction in the range of -2% to -8%.